Shionogi & Co., Ltd. (TYO:4507)

Revenue by Segment

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
Prescription Drugs	499.68B	438.27B	435.08B	426.68B	335.14B
Prescription Drugs Growth	14.01%	0.73%	1.97%	27.32%	12.77%
Total	499.68B	438.27B	435.08B	426.68B	335.14B
Total Growth	14.01%	0.73%	1.97%	27.32%	12.77%

Revenue by Geography

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
Japan	152.11B	130.00B	155.28B	207.78B	113.59B
Japan Growth	17.00%	-16.28%	-25.27%	82.92%	-4.22%
United States of America	33.09B	23.44B	18.03B	16.25B	14.32B
United States of America Growth	41.18%	29.98%	10.98%	13.44%	60.00%
Others	15.67B	19.15B	17.77B	17.67B	15.59B
Others Growth	-18.19%	7.81%	0.54%	13.36%	3.17%
Europe (Excl. UK)	31.95B	20.16B	17.70B	10.28B	7.43B
Europe (Excl. UK) Growth	58.47%	13.89%	72.27%	38.36%	-18.02%
United Kingdom	266.86B	245.51B	201.29B	174.71B	184.20B
United Kingdom Growth	8.70%	21.97%	15.22%	-5.16%	26.64%
North America (Excl. US)	-	-	5.00M	6.00M	8.00M
North America (Excl. US) Growth	-	-	-16.67%	-25.00%	-33.33%
Total	499.68B	438.27B	410.07B	426.68B	335.14B
Total Growth	14.01%	6.88%	-3.89%	27.32%	12.77%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 18, 2026

Data Sources Report a data error